HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

Inventors: Tomoya Miyakawa (Tokyo, JP); Masaaki Oka (Yamaguchi, JP); Shoichi Hazama (Yamaguchi, JP); Koji Tamada (Yamaguchi, JP); Keiko Udaka (Kochi, JP)

Assignee: Cytlimic Inc.

A61K39/0011 A61K38/00 A61K38/1764 A61K39/00 A61K47/50 C07K7/06 C12N15/09 A61K2039/545

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 10,537,626
App. No.: 15/516,918
Granted: Jan 21, 2020
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.

Claims (2)

1. A method for producing an antigen-presenting cell having a CTL inducing activity, comprising a step of contacting a peptide consisting of the amino acid sequence of SEQ ID NO: 7 with an antigen-presenting cell in vitro.

2. The method according to claim 1 , wherein the peptide can bind to one or more types of HLA molecules.

Assignments (7)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2023

From: CYTLIMIC INC.

To: NEC CORPORATION

Reel/Frame 062357/0203 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2018

From: MIYAKAWA, TOMOYA

To: NEC CORPORATION

Reel/Frame 044893/0898 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2018

From: OKA, MASAAKI; HAZAMA, SHOICHI; TAMADA, KOJI